Share Twitter LinkedIn Facebook Email Ithaar H. Derweesh, M.D., University of California, San Diego asks the question “Neoadjuvant Therapy: Where are we in 2016?” at the 2016 annual International Kidney Cancer Symposium.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read